Vogt-Koyanagi-Harada-like uveitis as an immune-related adverse event of BRAF/MEK inhibitor treatment

被引：0
|
作者：
Nakajima, I. [1 ]
Yoshino, K. [2 ]
Tsuji, H. [1 ]
机构：
[1] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Ophthalmol, kotoku, Tokyo, 1358555, Japan
[2] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Dermatol Oncol, Kotoku, Tokyo 1358555, Japan
来源：
JOURNAL FRANCAIS D OPHTALMOLOGIE | 2025年 / 48卷 / 02期
关键词：
D O I：
10.1016/j.jfo.2024.104357
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Vogt-Koyanagi-Harada-like Syndrome Induced by Checkpoint Inhibitor Cemiplimab
    Huang, Ye
    Khan, Farid
    Saraiya, Nehali V.
    Punjabi, Omar S.
    Gulati, Vikas
    Erickson, Alan R.
    Yeh, Steven
    JOURNAL OF IMMUNOTHERAPY, 2023, 46 (08) : 295 - 298
  • [2] Erratum zu: Vogt-Koyanagi-Harada-artige Uveitis unter Immun-Checkpoint-Inhibitor-Therapie beim metastasierten malignen MelanomErratum to: Vogt-Koyanagi-Harada-like uveitis under immune checkpoint inhibitor treatment for metastasized malignant melanoma
    Nataša Mihailovic
    Jörg Dyballa
    Saskia Herz
    Michael Fluck
    Maged Alnawaiseh
    Ralph-Laurent Merté
    Nicole Eter
    Der Ophthalmologe, 2020, 117 (5): : 472 - 473
  • [3] A case of Vogt-Koyanagi-Harada-like uveitis secondary to dabrafenib/trametinib therapy for advanced melanoma
    Brambati, Maria
    Giuffre, Chiara
    Marchese, Alessandro
    Bandello, Francesco
    Modorati, Giulio Maria
    Miserocchi, Elisabetta
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2022, 32 (01) : NP109 - NP113
  • [4] Case with metastatic cutaneous malignant melanoma that developed Vogt-Koyanagi-Harada-like uveitis following pembrolizumab treatment
    Enomoto, Hiroko
    Kato, Kumiko
    Sugawara, Asako
    Itabashi, Moe
    Kondo, Mineo
    DOCUMENTA OPHTHALMOLOGICA, 2021, 142 (03) : 353 - 360
  • [5] Vogt-Koyanagi-Harada-like Syndrome Complicating Pembrolizumab Treatment for Metastatic Melanoma
    Bricout, Marion
    Petre, Adeline
    Amini-Adle, Mona
    Bezza, Widad
    Seve, Pascal
    Kodjikian, Laurent
    Dalle, Stephane
    Thomas, Luc
    JOURNAL OF IMMUNOTHERAPY, 2017, 40 (02) : 77 - 82
  • [6] Vogt-Koyanagi-Harada-like syndrome induced by immune checkpoint inhibitors in a patient with melanoma
    Yoshida, S.
    Shiraishi, K.
    Mito, T.
    Sayama, K.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2020, 45 (07) : 908 - 911
  • [7] Vogt-Koyanagi-Harada-like disease secondary to anticancer treatment: a multicentre case series
    Urzua, Cristhian A.
    Olate-Perez, Alvaro
    Anguita, Rodrigo
    Schlaen, Ariel
    Munk, Marion R.
    Carreno, Ester
    Garza-Leon, Manuel
    Sainz-de-la-Maza, Maite
    Adan, Alfredo
    Takeuchi, Masaru
    Pavesio, Carlos
    Sabat, Pablo E.
    Labbe, Eduardo
    Duarte, Gonzalo
    Couto, Cristobal
    Cuitino, Loreto
    Arellanes-Garcia, Lourdes
    Fuseau, Michelle
    Cairoli, Ernesto
    Vidal, Rodrigo
    Curi, Andre
    de-la-Torre, Alejandra
    Concha-del-Rio, Luz Elena
    EYE, 2025,
  • [8] Vogt-Koyanagi-Harada-like Uveitis under Immune Checkpoint Inhibitor Treatment for metastasized malignant Melanoma (Sep, 10.1007/s00347-019-00963-z, 2019)
    Mihailovic, Natasa
    Dyballa, Joerg
    Herz, Saskia
    Fluck, Michael
    Alnawaiseh, Maged
    Merte, Ralph-Laurent
    Eter, Nicole
    OPHTHALMOLOGE, 2020, 117 (05): : 472 - 473
  • [9] Bilateral Nivolumab-associated Vogt-Koyanagi-Harada-like Uveitis in a Patient with Metastatic Renal Cell Carcinoma
    Czichos, Carolina
    Wawrzynow, Bartlomiej
    Chamalis, Christos
    von Jagow, Burkhard
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2021, 238 (06) : 711 - 714
  • [10] Vogt-Koyanagi-Harada-Like Uveitis Secondary to Pembrolizumab in Metastatic Gastric Cancer: A Case Report and Review of the Literature
    Denu, Ryan A.
    Mcdermott, John J.
    Patel, Shivani C.
    Patel, Tejal
    Dahr, Sami S.
    CASE REPORTS IN ONCOLOGY, 2024, 17 (01): : 1071 - 1086
12345